TalkMed (SGX:5G3) appointed KPMG Corporate Finance as independent financial adviser for the proposed privatization of the company by way of a scheme of arrangement, according to a filing with the Singapore Exchange on Thursday.
In an earlier filing, TW Troy offered to acquire all the issued and paid-up shares in the company's capital by way of a scheme of arrangement.
TW Troy would pay or procure a payment of SG$0.456 in cash per scheme share held by shareholders.
Shares of the company gained over 1% in recent trade.
Price (SGD): S$0.45, Change: S$+0.0050, Percent Change: +1.12%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.